Trial Profile
Phase II Study for Maintenance IBI308 in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Oct 2018
Price :
$35
*
At a glance
- Drugs Sintilimab (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 23 Oct 2018 New trial record